Who are the Board of Directors?
The Board consists of 10 people elected by the members of the Association - five from companies in the Industry Division and five from companies in the Agencies and Consultancies Division (including Personal members).
Board members all work full time in healthcare business intelligence roles, but have the support of their organisations to commit time and energy to BHBIA initiatives in addition to their day jobs.
Most Board members are in senior BI positions (industry department head or agency director level or above) but applications from a spectrum of roles are welcomed as it is recognised that all committee members have something different to contribute.
What's involved in being on the Board of Directors?
Board members play a vital role in setting the strategic direction of the BHBIA. In addition to taking part in monthly Board meetings, Board members are expected to attend key meetings such as the Annual Conference, and to help with the organisation and running of other initiatives and events. All members need to be prepared to take a ‘hands on’ approach to share this commitment.
Below is what some previous Committee/Board members have said about being on Committee/Board:
“The people are great! And the meetings are always very democratic. It’s been nice to have an input into the direction of the BHBIA, to know in advance what’s going to happen, and to be involved in shaping things. Being the BHBIA lead within my company has also motivated me to take more notice of updates. I’ve enjoyed watching and learning from other committee members – seeing other people’s approach to the same problems and challenges that I faced and then taking the learnings back to my own role. I also liked being ‘nosy’ and going to other companies’ offices to see how the other half lived! I really enjoyed the training courses and especially running the foundation courses. Hopefully I have managed to help inspire some people – I’ve been gratified to see some of my ‘trainees’ on the platform at Conference and the Winter Seminar”
Stewart West, Janssen
“I really enjoyed my time on the committee and was sorry to have to leave. One of the best things is the people – who are passionate about what they do. The interaction and debate in meetings were very stimulating and it is satisfying to be able to have an influence over the direction of the organisation. My experience is that BHBIA is very engaged with its members and forward thinking in terms of dealing with the issues that we face every day as researchers”
Julie Curphey, Pfizer
How are the Board of Directors elected?
A request for nominations for membership of the Board is sent to all members before the end of December each year, with 31st January as the closing date for nominations.
The formal nomination process for the 2021 Board has now closed, but as of June 2021 we have two current vacancies for pharma members to be co-opted onto the Board - see more information here
In the event that more nominations are received than the number of vacancies available, there is a ballot (for either the Industry or the Agency Divisions of the Board, or both, as applicable), following which the candidates with the most votes are elected. Note: candidates are elected by members of their own division – i.e. pharma companies vote for the pharma person they would most like to represent them, and agencies vote for the agency person. (Each organisation has only one vote).
The term of office is two years, after which Board members who wish to continue their service can stand for re-election.
If a Board member resigns before the end of their term of office, the rest of the Board can chose to ‘co-opt’ someone to fill their post on a temporary basis. The co-opted member must then be nominated and, if applicable, stand for election alongside other nominees if they subsequently want to join the Board on a formal basis.